Saltar al contenido
Merck

Substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4 towards galactose, glucose, and their derivatives.

Bioorganic & medicinal chemistry letters (2012-04-20)
Yang Zou, Wenjun Wang, Li Cai, Leilei Chen, Mengyang Xue, Xiaomei Zhang, Jie Shen, Min Chen
RESUMEN

Galactokinases (GalKs) have attracted significant research attention for their potential applications in the enzymatic synthesis of unique sugar phosphates. The galactokinase (GalKSpe4) cloned from Streptococcus pneumoniae TIGR4 presents a remarkably broad substrate range including 14 diverse natural and unnatural sugars. TLC and MS studies revealed that GalKSpe4 had relaxed activity towards galactose derivatives with modifications on the C-6, 4- or 2-positions. Additionally, GalKSpe4 can also tolerate glucose while glucose derivatives with modifications on the C-6, 4- or 2-positions were unacceptable. More interestingly, GalKSpe4 can phosphorylate L-mannose in moderate yield (43%), while other L-sugars such as L-Gal cannot be recognized by this enzyme. These results are very significant because there is rarely enzyme reported that can phosphorylate such uncommon substrates as l-mannose.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
L-(−)-Mannose, ≥99% (GC)
Sigma-Aldrich
Galactokinase human, recombinant, expressed in E. coli